BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 21093909)

  • 1. Direct and indirect effects of functionalised fluorescence-labelled nanoparticles on human osteoclast formation and activity.
    Tautzenberger A; Kreja L; Zeller A; Lorenz S; Schrezenmeier H; Mailänder V; Landfester K; Ignatius A
    Biomaterials; 2011 Feb; 32(6):1706-14. PubMed ID: 21093909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-17A induces cathepsin K and MMP-9 expression in osteoclasts via celecoxib-blocked prostaglandin E2 in osteoblasts.
    Zhang F; Tanaka H; Kawato T; Kitami S; Nakai K; Motohashi M; Suzuki N; Wang CL; Ochiai K; Isokawa K; Maeno M
    Biochimie; 2011 Feb; 93(2):296-305. PubMed ID: 20937352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation of human osteoclasts formed in vitro: hormonal effects on the bone-resorbing activity of human osteoclasts.
    Kudo O; Sabokbar A; Pocock A; Itonaga I; Athanasou NA
    Calcif Tissue Int; 2002 Dec; 71(6):539-46. PubMed ID: 12232680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
    Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
    J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells.
    Kitami S; Tanaka H; Kawato T; Tanabe N; Katono-Tani T; Zhang F; Suzuki N; Yonehara Y; Maeno M
    Biochimie; 2010 Apr; 92(4):398-404. PubMed ID: 20045440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of strontium-substituted bioactive glasses on osteoblasts and osteoclasts in vitro.
    Gentleman E; Fredholm YC; Jell G; Lotfibakhshaiesh N; O'Donnell MD; Hill RG; Stevens MM
    Biomaterials; 2010 May; 31(14):3949-56. PubMed ID: 20170952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation and functions of osteoclasts and odontoclasts in mineralized tissue resorption.
    Sasaki T
    Microsc Res Tech; 2003 Aug; 61(6):483-95. PubMed ID: 12879416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age of donor alters the effect of cyclic hydrostatic pressure on production by human macrophages and osteoblasts of sRANKL, OPG and RANK.
    Evans CE; Mylchreest S; Andrew JG
    BMC Musculoskelet Disord; 2006 Mar; 7():21. PubMed ID: 16519799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclast 121F antigen expression during osteoblast conditioned medium induction of osteoclast-like cells in vitro: relationship to calcitonin responsiveness, tartrate resistant acid phosphatase levels, and bone resorptive activity.
    Collin-Osdoby P; Oursler MJ; Rothe L; Webber D; Anderson F; Osdoby P
    J Bone Miner Res; 1995 Jan; 10(1):45-58. PubMed ID: 7747630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cocultures of osteoblasts and osteoclasts are influenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating.
    Greiner S; Kadow-Romacker A; Schmidmaier G; Wildemann B
    J Biomed Mater Res A; 2009 Oct; 91(1):288-95. PubMed ID: 18980195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen and testosterone use different cellular pathways to inhibit osteoclastogenesis and bone resorption.
    Michael H; Härkönen PL; Väänänen HK; Hentunen TA
    J Bone Miner Res; 2005 Dec; 20(12):2224-32. PubMed ID: 16294275
    [TBL] [Abstract][Full Text] [Related]  

  • 12. (Pre-)osteoclasts induce retraction of osteoblasts before their fusion to osteoclasts.
    Perez-Amodio S; Beertsen W; Everts V
    J Bone Miner Res; 2004 Oct; 19(10):1722-31. PubMed ID: 15355568
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The differential regulation of osteoblast and osteoclast activity by surface topography of hydroxyapatite coatings.
    Costa DO; Prowse PD; Chrones T; Sims SM; Hamilton DW; Rizkalla AS; Dixon SJ
    Biomaterials; 2013 Oct; 34(30):7215-26. PubMed ID: 23830579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro differentiation of CD14 cells from osteopetrotic subjects: contrasting phenotypes with TCIRG1, CLCN7, and attachment defects.
    Blair HC; Borysenko CW; Villa A; Schlesinger PH; Kalla SE; Yaroslavskiy BB; Garćia-Palacios V; Oakley JI; Orchard PJ
    J Bone Miner Res; 2004 Aug; 19(8):1329-38. PubMed ID: 15231021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wnt signalling in osteoblasts regulates expression of the receptor activator of NFkappaB ligand and inhibits osteoclastogenesis in vitro.
    Spencer GJ; Utting JC; Etheridge SL; Arnett TR; Genever PG
    J Cell Sci; 2006 Apr; 119(Pt 7):1283-96. PubMed ID: 16522681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and gene expression of haematopoietic-cell-free preparations of highly purified murine osteocytes.
    Chia LY; Walsh NC; Martin TJ; Sims NA
    Bone; 2015 Mar; 72():34-42. PubMed ID: 25460578
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors.
    Chikazu D; Katagiri M; Ogasawara T; Ogata N; Shimoaka T; Takato T; Nakamura K; Kawaguchi H
    J Bone Miner Res; 2001 Nov; 16(11):2074-81. PubMed ID: 11697804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
    Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
    J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin K-sensitive poly(ethylene glycol) hydrogels for degradation in response to bone resorption.
    Hsu CW; Olabisi RM; Olmsted-Davis EA; Davis AR; West JL
    J Biomed Mater Res A; 2011 Jul; 98(1):53-62. PubMed ID: 21523904
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histochemical examination of osteoblastic activity in op/op mice with or without injection of recombinant M-CSF.
    Nishino I; Amizuka N; Ozawa H
    J Bone Miner Metab; 2001; 19(5):267-76. PubMed ID: 11498728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.